251 related articles for article (PubMed ID: 21778351)
1. CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload.
Madec S; Cerec V; Plée-Gautier E; Antoun J; Glaise D; Salaun JP; Guguen-Guillouzo C; Corlu A
Drug Metab Dispos; 2011 Oct; 39(10):1987-96. PubMed ID: 21778351
[TBL] [Abstract][Full Text] [Related]
2. CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis.
Antoun J; Goulitquer S; Amet Y; Dreano Y; Salaun JP; Corcos L; Plée-Gautier E
J Lipid Res; 2008 Oct; 49(10):2135-41. PubMed ID: 18566475
[TBL] [Abstract][Full Text] [Related]
3. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
[TBL] [Abstract][Full Text] [Related]
4. Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells.
Pant A; Rondini EA; Kocarek TA
Toxicol Appl Pharmacol; 2019 Feb; 365():61-70. PubMed ID: 30611723
[TBL] [Abstract][Full Text] [Related]
5. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
Luo L; Fang K; Dan X; Gu M
Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
[TBL] [Abstract][Full Text] [Related]
6. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
López-Oliva ME; Garcimartin A; Muñoz-Martínez E
Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
[TBL] [Abstract][Full Text] [Related]
7. Human cytochrome P450 4F3: structure, functions, and prospects.
Corcos L; Lucas D; Le Jossic-Corcos C; Dréano Y; Simon B; Plée-Gautier E; Amet Y; Salaün JP
Drug Metabol Drug Interact; 2012 Apr; 27(2):63-71. PubMed ID: 22706230
[TBL] [Abstract][Full Text] [Related]
8. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
Ducheix S; Podechard N; Lasserre F; Polizzi A; Pommier A; Murzilli S; Di Lisio C; D'Amore S; Bertrand-Michel J; Montagner A; Pineau T; Loiseau N; Lobaccaro JM; Martin PG; Guillou H
Biochimie; 2013 Mar; 95(3):556-67. PubMed ID: 23063693
[TBL] [Abstract][Full Text] [Related]
9. CYP4F2 repression and a modified alpha-tocopherol (vitamin E) metabolism are two independent consequences of ethanol toxicity in human hepatocytes.
Russo A; Bartolini D; Torquato P; Giusepponi D; Barola C; Galarini R; Birringer M; Lorkowski S; Galli F
Toxicol In Vitro; 2017 Apr; 40():124-133. PubMed ID: 28062356
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E).
Bartolini D; Torquato P; Barola C; Russo A; Rychlicki C; Giusepponi D; Bellezza G; Sidoni A; Galarini R; Svegliati-Baroni G; Galli F
J Nutr Biochem; 2017 Sep; 47():120-131. PubMed ID: 28628909
[TBL] [Abstract][Full Text] [Related]
11. Gene expressions of de novo hepatic lipogenesis in feline hepatic lipidosis.
Valtolina C; Robben JH; van Wolferen ME; Kruitwagen HS; Corbee RJ; Favier RP; Penning LC
J Feline Med Surg; 2020 Jun; 22(6):500-505. PubMed ID: 31322470
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor alpha is required for feedback regulation of highly unsaturated fatty acid synthesis.
Li Y; Nara TY; Nakamura MT
J Lipid Res; 2005 Nov; 46(11):2432-40. PubMed ID: 16106047
[TBL] [Abstract][Full Text] [Related]
13. Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides.
Le Quéré V; Plée-Gautier E; Potin P; Madec S; Salaün JP
J Lipid Res; 2004 Aug; 45(8):1446-58. PubMed ID: 15145985
[TBL] [Abstract][Full Text] [Related]
14. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
[TBL] [Abstract][Full Text] [Related]
15. p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis.
Xiong Y; Collins QF; An J; Lupo E; Liu HY; Liu D; Robidoux J; Liu Z; Cao W
J Biol Chem; 2007 Feb; 282(7):4975-4982. PubMed ID: 17172644
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.
Schadinger SE; Bucher NL; Schreiber BM; Farmer SR
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1195-205. PubMed ID: 15644454
[TBL] [Abstract][Full Text] [Related]
17. Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance.
Chang JJ; Hsu MJ; Huang HP; Chung DJ; Chang YC; Wang CJ
J Agric Food Chem; 2013 Jun; 61(25):6069-76. PubMed ID: 23731091
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha.
Goldwasser J; Cohen PY; Yang E; Balaguer P; Yarmush ML; Nahmias Y
PLoS One; 2010 Aug; 5(8):e12399. PubMed ID: 20811644
[TBL] [Abstract][Full Text] [Related]
19. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
20. Low abundance of mitofusin 2 in dairy cows with moderate fatty liver is associated with alterations in hepatic lipid metabolism.
Dong J; Loor JJ; Zuo R; Chen X; Liang Y; Wang Y; Shu X; Sun X; Jia H; Liu G; Wang Z; Li X; Li X
J Dairy Sci; 2019 Aug; 102(8):7536-7547. PubMed ID: 31178189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
